|
HS Code |
637623 |
| Compound Name | 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile, compd. with 2-hydroxypropionic acid |
| Molecular Formula | C13H9N3O · C3H6O3 |
| Molecular Weight | 324.32 g/mol |
| Appearance | Solid |
| Color | Light yellow to off-white |
| Solubility | Soluble in water and organic solvents |
| Melting Point | Approx. 150-155°C (decomposition may occur) |
| Storage Conditions | Store at room temperature in a dry place, airtight container |
| Cas Number | 871126-75-1 |
| Synonyms | Nicotinamide riboside chloride lactate salt |
| Ph | Neutral to slightly acidic in aqueous solution |
| Stability | Stable under recommended storage conditions |
| Usage | Research chemical; potential NAD+ precursor |
As an accredited 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile, compd. with 2-hydroxypropionic acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packaged in a 25g amber glass bottle with tamper-evident seal, labeled with compound’s name, CAS number, and safety information. |
| Container Loading (20′ FCL) | 20′ FCL loads 12MT net, packed in 25kg fiber drums, securely sealed, moisture-protected, with required labeling and documentation. |
| Shipping | The chemical `1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile, compd. with 2-hydroxypropionic acid` is shipped in tightly sealed containers, protected from light and moisture. It requires transport by certified carriers, following relevant regulations for safe handling of chemicals. Appropriate hazard labeling and documentation are provided as per international standards. |
| Storage | Store 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile, compd. with 2-hydroxypropionic acid in a cool, dry, well-ventilated area, away from direct sunlight and incompatible substances. Keep the container tightly closed and clearly labeled. Protect from moisture. Follow appropriate chemical storage regulations and handle with suitable personal protective equipment to avoid exposure and contamination. |
| Shelf Life | Shelf life: When stored tightly sealed at 2–8°C, protected from light and moisture, the compound remains stable for at least 2 years. |
|
Purity 99%: 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile, compd. with 2-hydroxypropionic acid of 99% purity is used in pharmaceutical intermediate synthesis, where it ensures high yield and product consistency. Melting point 180°C: 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile, compd. with 2-hydroxypropionic acid with a melting point of 180°C is used in high-temperature drug formulation processes, where it allows for stable handling and processing. Particle size D90 < 10 µm: 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile, compd. with 2-hydroxypropionic acid with particle size D90 < 10 µm is utilized in solid oral dosage manufacturing, where it promotes uniform dispersion and consistent tablet quality. Moisture content <0.5%: 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile, compd. with 2-hydroxypropionic acid featuring moisture content below 0.5% is employed in lyophilized injectable formulations, where it prevents degradation and extends shelf life. Stability temperature up to 70°C: 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile, compd. with 2-hydroxypropionic acid stable up to 70°C is applied in bulk chemical storage, where it maintains chemical integrity during transport and warehousing. Molecular weight 295.29 g/mol: 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile, compd. with 2-hydroxypropionic acid with molecular weight 295.29 g/mol is used in research assays, where accurate stoichiometry is required for reproducible experimental results. HPLC purity ≥98%: 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile, compd. with 2-hydroxypropionic acid with HPLC purity ≥98% is used in reference standard preparation, where analytical accuracy is essential for calibration purposes. Residual solvents <10 ppm: 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile, compd. with 2-hydroxypropionic acid with residual solvents less than 10 ppm is implemented in GMP manufacturing processes, where it minimizes toxicity risks in final pharmaceutical products. |
Competitive 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile, compd. with 2-hydroxypropionic acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
At the production floor, fine-tuning the synthesis of 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile compounded with 2-hydroxypropionic acid translates into solid hours of hands-on chemistry and experienced judgment. Our job as the manufacturer isn’t just about formulas and specs—it’s about every step affecting the chemical’s reliability, purity, and value for users pushing research and process boundaries.
This product doesn’t cut corners in terms of precision. It stands apart due to our process controls and the way we’ve addressed structure and stability through compounded formulation. Many similar bipyridine derivatives remain unstable in fluctuating environmental conditions; our compound demonstrates impressive shelf stability because of its combination with 2-hydroxypropionic acid. We’ve paid close attention to moisture control during synthesis, all the way from raw material selection to the drying process, since water introduction can influence crystallization and downstream use.
Customers often discuss analytical readings but as the manufacturer, we see every minute point where contamination might creep in. In our experience, the route to high-purity 1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile centers on precise timing of reaction steps and the use of in-line analytical checks, rather than relying only on end-point assays. We keep consistent purity—verified beyond standard HPLC, often cross-checked with NMR or MS. This ensures lot-to-lot reliability for customers pressing for reproducibility, be it pharmaceutical research, specialty polymers, or material sciences.
Adulterants and byproducts can frustrate end users, as we’ve learned through years of optimization. Our team focused on crystallization protocols that prevent isomerization, a recurring issue in bipyridine chemistry. This kind of process refinement arose from repeated lab-scale surprises: unplanned impurities, sometimes in micropercent ranges, causing issues downstream. To reduce such noise, we put extra effort into solvent recovery and controlled cooling, yielding tighter product specification.
We manufacture this compound by reacting the parent pyridine structure under carefully monitored low-temperature conditions, followed by direct combination with 2-hydroxypropionic acid under dry atmosphere. The process isn’t only about getting the stoichiometry right; even a fractional deviation in temperature or the time spent in each process stage can tilt the balance toward undesired polymorphs. Our plant engineers adjust for these factors every batch, reviewing crystallization rates and recording observations.
Over the years, we've moved away from bulk-batch methods toward continuous flow reactors for this specific compound. In one case, large-scale batch synthesis led to shifts in the product phase during high humidity seasons. Switching to smaller, but more controlled, flow synthesis solved this and created opportunities to lower residual solvent content. Endpoint titration and Karl Fischer analysis now form part of our workflow to back our purity claims with hard data.
Some might overlook the importance of the acid in the complex, but we’ve seen its influence in real-world storage, handling, and usage. Acid stabilizes the otherwise sensitive bipyridine derivative, leading to enhanced solubility profiles. Customers working in organic solvents, as well as aqueous systems, benefit from this stability. We found early on—through collaboration with material scientists—that without this counterion, product performance dropped when exposed to ambient air over several weeks. Retained acid content plays an additional role during thermal processing, widening the usable temperature range compared to un-compounded analogues.
The compound proves particularly useful for researchers synthesizing heterocyclic libraries, and for those investigating catalyst ligands. The acid component can serve as a hydrogen bond donor in crystal engineering projects or pharmaceutical intermediates. Teams working in R&D environments reported reproducible recrystallization and fewer solid-state transformations, offering greater confidence when scaling up or moving into formulation stage.
Product quality doesn’t reside in marketing charts—it gets built during production runs, and our feedback loop is direct. Chromatograms from pilot batches told us where impurities like 5-methyl or 3-cyano derivatives peaked. We designed our workflow to minimize these, first by adjusting molar ratios in the input, then by altering the order of isolation and acid addition. Those tweaks made visible improvements: reduced color bodies, less particulate after recrystallization, cleaner melting points, and more consistent mass spec readings batch to batch.
The particle size reflects our control over grinding and drying. Fine, free-flowing powders often mean greater surface area and easier dispersion, but clumping can arise if moisture isn’t held low. We observed this directly—early stage production ran into caking, leading us to test differing sieve sizes and adjust vacuum drying cycles. Final product typically sits well within 150–250 μm range, offering process advantages for users dissolving or blending the compound.
Getting to know competing products reveals the choices behind each manufacturer’s approach. We noticed considerable batch-to-batch difference in commercial samples bought from domestic and international providers. Our material, adjusted for acid content and impurity profile, avoids the yellowing or oily residues sometimes found elsewhere. Our acid-base pairing specifically addresses shelf stability backed by real-time storage studies at 25°, 35°, and 45°C over 12 months.
Non-compounded bipyridines may degrade faster and often present purification problems if used beyond strictly anhydrous or inert conditions. Some producers offer the non-acidified form, but those powders have attracted complaint for shorter shelf life or inconsistent reactivity in cross-coupling chemistry. The compounded product ships with the stabilized, crystallized salt form, delivering longer usable life without the same sensitivity to air and ambient light. For teams in high-throughput screening, fewer failed runs saves considerable time and cost.
Another key point: our process eliminates persistent trace metals, common when metal-catalyzed synthetic routes are employed on large scale. This distinction matters in pharmaceuticals, where metal contamination requires extra purification. By adopting non-metal catalysis, we offer a cleaner product. HPLC and MS analyses across several lots confirm the absence of problematic contaminants, and our customers in medicinal chemistry value that reliability.
As a manufacturer, customer feedback shapes continual process improvements. Organic synthesis teams prefer our compounded bipyridine because it dissolves quickly in most polar and non-polar solvents. Stability in these solutions stands out—researchers in academic and industry labs have expressed that their samples remain clear and active for extended periods, reducing prep work and improving yield predictability.
Materials R&D, especially in supramolecular chemistry, places high value on clean hydrogen bonding patterns. The acid partner in the complex helps in building layered, stable structures during slow crystallization. Pharmaceutical researchers pointed out smoother analytical profiles due to fewer polymorphic forms—something we observed too as our own QC staff tracked shifts over several months of accelerated aging.
Our technical support team frequently hears from teams working under tight timelines. In those settings, any deviation—such as batch outliers in crystal habit or unexpected solvation—becomes a costly delay. By standardizing not just the chemical process, but the conditioning and blending, we've allowed those groups to run more consistent first-pass screens. Several CRO partners credited the compound for improved throughput in combinatorial synthesis campaigns.
Manufacturing specialty chemicals demands not just time, but resilience—unplanned shutdowns, supply bottlenecks, and unpredictable raw material quality always shape outcomes. High purity bipyridine chemistry is unforgiving in that regard. During a quarter marked by global solvent shortages, we maintained product standards by qualifying alternate solvents and ramping up solvent recovery. That effort required daily oversight, frequent recalibration, and adjusting work shifts, but it also built site-wide flexibility into our process.
Storage and handling posed their own problems. Without controlled humidity, the compounded product exhibited slow caking in sealed drums, an issue some manufacturers tolerate but which caused headaches at customer sites. We focused on improved bulk packaging—adding moisture-absorbing liners and validating new carriers for air freight. The result: bulk shipments arriving with their original flow properties intact, no accelerated caking, no off-odors creeping in. Plant operators noted reduced rework rates, and customers reported cleaner transfers.
As demand for regulatory assurance grows, even minor batch variations trigger requests for documentation and investigation. We keep careful records and offer detailed batch data, supporting users pursuing drug master files or regulatory submissions. Labs moving into pre-clinical studies found our robust documentation—verified analytical methods, stability profiles, and elemental analysis reports—meets both internal QA and external audit requirements.
With each production cycle, staff gather performance data—crystallization kinetics, solvent-profile compatibility, storage outcomes. Every operator’s contribution counts: those notes become the push for retuning reactor configurations or trying out improved filtrations. Recent months saw a shift toward membrane-based purification, yielding better control over particle habit and trace residue levels.
Even under pressure to deliver larger quantities, we guard against process shortcuts. Our internal audits catch deviations quickly, and we invest in training to make sure every step reflects what we expect from a premium compound. We run ongoing stability tests outside of official release, keeping our own reference samples under alternate storage to flag any drift in properties. Real performance data beats theoretical shelf claims, and these measures give us—and our customers—confidence in extended supply contracts.
Years at the production line reveal where sustainability fits into the picture. For this product, solvent recycling, energy-efficient reaction design, and waste stream treatment are priorities baked into daily operations. Operators track solvent usage and recycle rates, aiming for tight recovery targets. We designed process water management to prevent any acid buildup affecting municipal treatment; our staff regularly audit and report improvement opportunities.
Some competitors rely on disposable equipment or send significant solvent waste off-site. By focusing on in-house reclamation and reuse, we reduce both cost and environmental impact, which ultimately benefits our buyers, too. Customers in regulated industries ask about supply chain transparency—our team prepares lifecycle assessments and is open about reagent sources, so users know exactly what goes into this compound. These steps reinforce our responsibilities as both supplier and corporate citizen.
Chemical production creates hidden differences, not always visible in a standard COA. Our experience shows that solvent-exposed synthesis often leaves stubborn traces, impacting reactivity and stability. We go further by integrating advanced drying and in-process gas sweeping, a step others might skip for bulk runs. The compounded form chosen for this product reflects repeated side-by-side use tests—not just analytical data but how the product behaves in real recipes and pilot-scale experiments.
Customers sometimes ask if non-acidified or substituted bipyridines can serve as economical alternatives. We direct those conversations using field evidence: storage tests, batch-to-batch performance in medicinal chemistry campaigns, and actual process yields. In every case, compounded forms outperformed with fewer downstream purification steps, less decomposition under moderate heat, and near-zero loss on storage.
End users value these distinctions. When major flavor and fragrance producers trialed multiple sources, our compound performed with higher solubility in their test formulations. Similar reports came from academic programs designing coordination complexes—repeat order rates climbed as users found less batch-to-batch adjustment needed. These outcomes stem directly from our production approach and quality focus.
The market for advanced bipyridine derivatives continues to expand, with applications running from catalysis and material science to pharmaceuticals and specialty intermediates. Every customer operates in a different environment, but the core need remains: reproducible, high-purity compounds delivered with full transparency and traceability. We listen to new project requirements and keep our R&D group engaged with feedback from plant technicians, not just external partners.
Innovation speaks not only through new molecules, but in how we approach existing products. We welcome technical inquiries and share insights learned from years of actual manufacturing experience. By staying close to the process, we support users facing greater supply chain scrutiny and tighter end-use regulations. The compound described here stands as a result of collaborative effort—driven by customers who value practical quality and a supplier willing to invest in continuous process improvement.